Higher intra-tumoral interleukin-17-producing Tregs have also been consistently reported in HCC and correlated with poorer prognosis and reduced survival in HCC patients (30, 37, 38, 40, 41). The gene discussed is IL17A; the disease is hepatocellular carcinoma.